Related references
Note: Only part of the references are listed.Changes in Resurgent Sodium Current Contribute to the Hyperexcitability of Muscles in Patients with Paramyotonia Congenita
Chiung-Wei Huang et al.
BIOMEDICINES (2021)
Cannabidiol inhibits the skeletal muscle Nav1.4 by blocking its pore and by altering membrane elasticity
Mohammad-Reza Ghovanloo et al.
JOURNAL OF GENERAL PHYSIOLOGY (2021)
New Insights on Hemp Oil Enriched in Cannabidiol: Decarboxylation, Antioxidant Properties and In Vitro Anticancer Effect
Anca Roxana Petrovici et al.
ANTIOXIDANTS (2021)
Substituted cysteine scanning in D1-S6 of the sodium channel hNav1.4 alters kinetics and structural interactions of slow inactivation
Jonathan M. Beard et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2020)
Cannabidiol protects against high glucose-induced oxidative stress and cytotoxicity in cardiac voltage-gated sodium channels
Mohamed A. Fouda et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Say Cheese: Structure of the Cardiac Electrical Engine Is Captured
Mohammad-Reza Ghovanloo et al.
TRENDS IN BIOCHEMICAL SCIENCES (2020)
Changes of Resurgent Na+ Currents in the Nav1.4 Channel Resulting from an SCN4A Mutation Contributing to Sodium Channel Myotonia
Chiung-Wei Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Prolonged oral transmucosal delivery of highly lipophilic drug cannabidiol
Constantin Itin et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Sodium Channel Myotonia Due to Novel Mutations in Domain I of Nav1.4
Serena Pagliarani et al.
FRONTIERS IN NEUROLOGY (2020)
Cannabidiol interactions with voltage-gated sodium channels
Lily Goodyer Sait et al.
ELIFE (2020)
Biophysical Characterization of a Novel SCN5A Mutation Associated With an Atypical Phenotype of Atrial and Ventricular Arrhythmias and Sudden Death
Mohammad-Reza Ghovanloo et al.
FRONTIERS IN PHYSIOLOGY (2020)
Inhibition of neuronal Na+ currents by lacosamide: Differential binding affinity and kinetics to different inactivated states
Yi-Shuan Peng et al.
NEUROPHARMACOLOGY (2020)
A meta-opinion: cannabinoids delivered to oral mucosa by a spray for systemic absorption are rather ingested into gastro-intestinal tract: the influences of fed / fasting states
Constantin Itin et al.
EXPERT OPINION ON DRUG DELIVERY (2019)
Clinicians' Guide to Cannabidiol and Hemp Oils
Harrison J. VanDolah et al.
MAYO CLINIC PROCEEDINGS (2019)
Overlap of periodic paralysis and paramyotonia congenita caused by SCN4A gene mutations two family reports and literature review
Shan Huang et al.
CHANNELS (2019)
Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis
Nicola Black et al.
LANCET PSYCHIATRY (2019)
Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons
Alex Straiker et al.
MOLECULAR PHARMACOLOGY (2018)
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
A Mixed Periodic Paralysis & Myotonia Mutant, P1158S, Imparts pH-Sensitivity in Skeletal Muscle Voltage-gated Sodium Channels
Mohammad-Reza Ghovanloo et al.
SCIENTIFIC REPORTS (2018)
Inhibitory effects of cannabidiol on voltage-dependent sodium currents
Mohammad-Reza Ghovanloo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Structure of the human voltage-gated sodium channel Nav1.4 in complex with β1
Xiaojing Pan et al.
SCIENCE (2018)
Fenestrations control resting-state block of a voltage-gated sodium channel
Tamer M. Gamal El-Din et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
N1366S mutation of human skeletal muscle sodium channel causes paramyotonia congenita
Qing Ke et al.
JOURNAL OF PHYSIOLOGY-LONDON (2017)
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol
Reesha R. Patel et al.
BRAIN (2016)
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
Orrin Devinsky et al.
LANCET NEUROLOGY (2016)
Physiological and Pathophysiological Insights of Nav1.4 and Nav1.5 Comparison
Gildas Loussouarn et al.
FRONTIERS IN PHARMACOLOGY (2016)
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation
Sumner Burstein
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: A comparison with carbamazepine, oxcarbazepine and lacosamide
Simon Hebeisen et al.
NEUROPHARMACOLOGY (2015)
Eslicarbazepine Acetate: A Review of Its Use as Adjunctive Therapy in Refractory Partial-Onset Seizures
Gillian M. Keating
CNS DRUGS (2014)
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
Orrin Devinsky et al.
EPILEPSIA (2014)
The adverse event profile of lacosamide: A systematic review and meta-analysis of randomized controlled trials
Gaetano Zaccara et al.
EPILEPSIA (2013)
Local anesthetic inhibition of a bacterial sodium channel
Sora Lee et al.
JOURNAL OF GENERAL PHYSIOLOGY (2012)
Voltage-gated sodium channels at 60: structure, function and pathophysiology
William A. Catterall
JOURNAL OF PHYSIOLOGY-LONDON (2012)
Screening for mutations in Spanish families with myotonia. Functional analysis of novel mutations in CLCN1 gene
Maria J. Mazon et al.
NEUROMUSCULAR DISORDERS (2012)
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
Alline Cristina Campos et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour
Serena Deiana et al.
PSYCHOPHARMACOLOGY (2012)
Differential regulation of Navβ subunits during myogenesis
Miren David et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2008)
YidC-mediated membrane insertion of assembly mutants of subunit C of the F1F0 ATPase
Stefan Kol et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Paralysis periodica paramyotonica caused by SCN4A Arg1448Cys mutation
Wei-Chih Hsu et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2006)
Myotonia and disorders of altered muscle cell membrane excitability
CH Vite
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE (2002)
Share Paper
